Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Strategic planning for measles control: using data to inform optimal vaccination strategies.

Simons E, Mort M, Dabbagh A, Strebel P, Wolfson L.

J Infect Dis. 2011 Jul;204 Suppl 1:S28-34. doi: 10.1093/infdis/jir095.

PMID:
21666174
2.

The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.

Bishai D, Johns B, Nair D, Nabyonga-Orem J, Fiona-Makmot B, Simons E, Dabbagh A.

J Infect Dis. 2011 Jul;204 Suppl 1:S107-15. doi: 10.1093/infdis/jir131.

3.

Progress toward measles elimination--Japan, 1999-2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Sep 26;57(38):1049-52.

4.

[Cost-effectiveness analysis of routine immunization for varicella in Japan].

Sugawara T, Ohkusa Y, Oikawa K, Haneda N, Kikuchi K, Kato F, Yamaguchi S, Okabe N.

Kansenshogaku Zasshi. 2006 May;80(3):212-9. Japanese.

PMID:
16780127
5.
6.

Policy evaluation for the subsidy for influenza vaccination in elderly.

Ohkusa Y.

Vaccine. 2005 Mar 18;23(17-18):2256-60.

PMID:
15755606
7.

[Cumulative vaccination coverage of measles- and oral polio vaccine obtained by the nationwide survey].

Takayama N, Sakiyama H, Miyamura T, Kato T.

Kansenshogaku Zasshi. 2005 Jan;79(1):7-12. Japanese.

PMID:
15717477
8.

Why is measles still endemic in Japan?

Gomi H, Takahashi H.

Lancet. 2004 Jul 24-30;364(9431):328-9. No abstract available.

PMID:
15276387
9.

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.

Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.

J Infect Dis. 2004 May 1;189 Suppl 1:S131-45.

PMID:
15106102
10.
11.

Economic evaluation of vaccination programs: the impact of herd-immunity.

Brisson M, Edmunds WJ.

Med Decis Making. 2003 Jan-Feb;23(1):76-82.

PMID:
12583457
12.

Development of vaccination policy in Japan: current issues and policy directions.

Nakatani H, Sano T, Iuchi T.

Jpn J Infect Dis. 2002 Aug;55(4):101-11. Review.

PMID:
12403906
13.
14.

Economic impact of influenza vaccination in preschool children.

Cohen GM, Nettleman MD.

Pediatrics. 2000 Nov;106(5):973-6.

PMID:
11061762
15.

A benefit-cost analysis of two-dose measles immunization in Canada.

Pelletier L, Chung P, Duclos P, Manga P, Scott J.

Vaccine. 1998 May-Jun;16(9-10):989-96.

PMID:
9682349
16.

The effectiveness of vaccination against influenza in healthy, working adults.

Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M.

N Engl J Med. 1995 Oct 5;333(14):889-93.

17.

Japan's medical care system.

Iglehart JK.

N Engl J Med. 1988 Sep 22;319(12):807-12. No abstract available.

PMID:
3412412
18.
19.

Cost-benefit calculations of vaccinations against measles and mumps in Austria.

Wiedermann G, Ambrosch F.

Dev Biol Stand. 1979;43:273-7.

PMID:
118067
20.

Costs and benefits of measles vaccination in Finland.

Ekblom M, Elo O, Laurinkari J, Niemelä P.

Scand J Soc Med. 1978;6(3):111-5.

PMID:
103198

Supplemental Content

Support Center